 Colleen McIlvennan
Concepts (273)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 51 | 2023 | 485 | 11.400 |
Why?
| | Heart Failure | 67 | 2023 | 1952 | 8.410 |
Why?
| | Caregivers | 20 | 2023 | 717 | 4.340 |
Why?
| | Decision Making | 15 | 2023 | 781 | 2.340 |
Why?
| | Terminal Care | 10 | 2022 | 213 | 2.270 |
Why?
| | Heart Transplantation | 7 | 2021 | 667 | 1.550 |
Why?
| | Palliative Care | 7 | 2019 | 641 | 1.360 |
Why?
| | Ventricular Function, Left | 4 | 2020 | 467 | 1.180 |
Why?
| | Quality of Life | 16 | 2023 | 2358 | 1.170 |
Why?
| | Choice Behavior | 2 | 2020 | 154 | 1.070 |
Why?
| | Ventricular Dysfunction, Left | 5 | 2023 | 359 | 1.070 |
Why?
| | Delivery of Health Care | 4 | 2023 | 833 | 1.040 |
Why?
| | Cardiology | 2 | 2019 | 259 | 1.010 |
Why?
| | Patient Care Team | 3 | 2019 | 517 | 0.970 |
Why?
| | Thrombosis | 3 | 2021 | 297 | 0.940 |
Why?
| | Health Knowledge, Attitudes, Practice | 6 | 2020 | 1183 | 0.890 |
Why?
| | Stress, Psychological | 3 | 2021 | 944 | 0.870 |
Why?
| | Emotions | 6 | 2023 | 472 | 0.850 |
Why?
| | Humans | 84 | 2023 | 114757 | 0.850 |
Why?
| | Heart Injuries | 1 | 2023 | 36 | 0.830 |
Why?
| | Physician-Patient Relations | 3 | 2020 | 462 | 0.820 |
Why?
| | Registries | 5 | 2021 | 1759 | 0.800 |
Why?
| | Patient Participation | 6 | 2022 | 360 | 0.780 |
Why?
| | Middle Aged | 32 | 2023 | 26757 | 0.720 |
Why?
| | Prosthesis Implantation | 3 | 2019 | 139 | 0.710 |
Why?
| | Palliative Medicine | 2 | 2017 | 14 | 0.700 |
Why?
| | Delirium | 1 | 2021 | 66 | 0.700 |
Why?
| | Patient Readmission | 2 | 2015 | 608 | 0.670 |
Why?
| | Biomedical Research | 3 | 2020 | 585 | 0.670 |
Why?
| | Risk Assessment | 6 | 2020 | 2973 | 0.630 |
Why?
| | Health Literacy | 2 | 2022 | 164 | 0.630 |
Why?
| | Patient Acceptance of Health Care | 3 | 2020 | 680 | 0.630 |
Why?
| | Attitude to Death | 2 | 2016 | 62 | 0.620 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 340 | 0.610 |
Why?
| | Coronavirus Infections | 2 | 2020 | 332 | 0.610 |
Why?
| | Betacoronavirus | 2 | 2020 | 252 | 0.600 |
Why?
| | Surveys and Questionnaires | 8 | 2023 | 4625 | 0.590 |
Why?
| | Male | 40 | 2023 | 55579 | 0.580 |
Why?
| | Quality Improvement | 4 | 2021 | 951 | 0.570 |
Why?
| | Hospice Care | 3 | 2016 | 185 | 0.570 |
Why?
| | Decision Making, Computer-Assisted | 1 | 2017 | 18 | 0.570 |
Why?
| | Female | 40 | 2023 | 59507 | 0.560 |
Why?
| | Patients | 2 | 2023 | 162 | 0.550 |
Why?
| | Caliciviridae Infections | 1 | 2016 | 17 | 0.550 |
Why?
| | Hospitalization | 4 | 2021 | 1752 | 0.550 |
Why?
| | Hospital Records | 1 | 2016 | 11 | 0.550 |
Why?
| | Mexiletine | 1 | 2016 | 7 | 0.540 |
Why?
| | Amphetamine | 1 | 2016 | 22 | 0.540 |
Why?
| | Physicians | 4 | 2020 | 772 | 0.530 |
Why?
| | Aged | 22 | 2023 | 19094 | 0.530 |
Why?
| | Myocardial Infarction | 1 | 2023 | 927 | 0.530 |
Why?
| | Bereavement | 1 | 2016 | 49 | 0.510 |
Why?
| | Substance Abuse Detection | 1 | 2016 | 62 | 0.510 |
Why?
| | Patient Preference | 5 | 2019 | 167 | 0.510 |
Why?
| | Cryosurgery | 1 | 2016 | 52 | 0.500 |
Why?
| | Depression | 2 | 2021 | 1133 | 0.500 |
Why?
| | Adaptation, Psychological | 8 | 2023 | 547 | 0.500 |
Why?
| | Transplant Recipients | 1 | 2016 | 140 | 0.490 |
Why?
| | Drug Monitoring | 1 | 2016 | 184 | 0.480 |
Why?
| | Patient-Centered Care | 4 | 2021 | 474 | 0.480 |
Why?
| | Partial Thromboplastin Time | 1 | 2014 | 51 | 0.470 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 268 | 0.470 |
Why?
| | Heart Diseases | 2 | 2017 | 330 | 0.470 |
Why?
| | Tachycardia, Ventricular | 1 | 2016 | 153 | 0.460 |
Why?
| | Heart Ventricles | 4 | 2021 | 709 | 0.460 |
Why?
| | Decision Support Techniques | 4 | 2020 | 351 | 0.450 |
Why?
| | Stroke Volume | 4 | 2023 | 508 | 0.450 |
Why?
| | Advance Care Planning | 2 | 2017 | 197 | 0.450 |
Why?
| | Research Design | 1 | 2019 | 931 | 0.440 |
Why?
| | Pandemics | 2 | 2020 | 1319 | 0.420 |
Why?
| | Qualitative Research | 5 | 2019 | 935 | 0.420 |
Why?
| | Blood Coagulation | 1 | 2014 | 217 | 0.420 |
Why?
| | Informed Consent | 1 | 2014 | 161 | 0.420 |
Why?
| | Adult | 21 | 2023 | 30548 | 0.420 |
Why?
| | Attitude to Health | 1 | 2016 | 406 | 0.410 |
Why?
| | Socioeconomic Factors | 1 | 2016 | 1078 | 0.410 |
Why?
| | Anticoagulants | 2 | 2021 | 547 | 0.390 |
Why?
| | Activities of Daily Living | 1 | 2014 | 350 | 0.370 |
Why?
| | Health Personnel | 2 | 2022 | 574 | 0.360 |
Why?
| | United States | 12 | 2020 | 12176 | 0.340 |
Why?
| | Treatment Outcome | 9 | 2023 | 9089 | 0.340 |
Why?
| | Program Development | 2 | 2023 | 342 | 0.310 |
Why?
| | Cardiovascular Diseases | 1 | 2019 | 1727 | 0.300 |
Why?
| | Substance-Related Disorders | 1 | 2016 | 947 | 0.300 |
Why?
| | Patient Education as Topic | 3 | 2018 | 679 | 0.290 |
Why?
| | Risk Factors | 9 | 2021 | 8627 | 0.290 |
Why?
| | Mental Health | 2 | 2023 | 560 | 0.270 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2020 | 1214 | 0.270 |
Why?
| | Withholding Treatment | 2 | 2016 | 68 | 0.260 |
Why?
| | Cost of Illness | 2 | 2020 | 254 | 0.260 |
Why?
| | Data Collection | 2 | 2019 | 622 | 0.240 |
Why?
| | Interviews as Topic | 3 | 2016 | 582 | 0.230 |
Why?
| | Communication | 3 | 2019 | 747 | 0.220 |
Why?
| | Troponin | 1 | 2023 | 44 | 0.210 |
Why?
| | Hospital Mortality | 2 | 2016 | 776 | 0.190 |
Why?
| | Trust | 1 | 2022 | 105 | 0.190 |
Why?
| | Home Nursing | 1 | 2020 | 26 | 0.180 |
Why?
| | Biomarkers | 2 | 2023 | 3416 | 0.170 |
Why?
| | BK Virus | 1 | 2019 | 14 | 0.170 |
Why?
| | Medicare | 2 | 2015 | 665 | 0.170 |
Why?
| | Thoracentesis | 1 | 2019 | 8 | 0.170 |
Why?
| | Family | 1 | 2023 | 591 | 0.170 |
Why?
| | Data Accuracy | 1 | 2019 | 48 | 0.160 |
Why?
| | Psychosocial Support Systems | 1 | 2019 | 12 | 0.160 |
Why?
| | Motion Pictures | 1 | 2019 | 13 | 0.160 |
Why?
| | Ethics Committees, Research | 1 | 2019 | 38 | 0.160 |
Why?
| | Viremia | 1 | 2019 | 123 | 0.160 |
Why?
| | Nurse Practitioners | 2 | 2019 | 102 | 0.160 |
Why?
| | Outpatients | 2 | 2023 | 327 | 0.160 |
Why?
| | Device Removal | 1 | 2020 | 126 | 0.160 |
Why?
| | Home Infusion Therapy | 1 | 2018 | 4 | 0.160 |
Why?
| | Chronic Disease | 3 | 2022 | 1590 | 0.150 |
Why?
| | Retrospective Studies | 10 | 2021 | 12515 | 0.150 |
Why?
| | Warfarin | 2 | 2021 | 135 | 0.150 |
Why?
| | Research Support as Topic | 1 | 2019 | 108 | 0.150 |
Why?
| | Organ Transplantation | 1 | 2020 | 159 | 0.150 |
Why?
| | Immunocompromised Host | 1 | 2019 | 195 | 0.150 |
Why?
| | Kaplan-Meier Estimate | 2 | 2019 | 815 | 0.150 |
Why?
| | Renal Insufficiency | 1 | 2019 | 136 | 0.150 |
Why?
| | Prospective Studies | 3 | 2020 | 6217 | 0.150 |
Why?
| | Cardiotonic Agents | 1 | 2018 | 119 | 0.150 |
Why?
| | Spouses | 1 | 2018 | 85 | 0.150 |
Why?
| | Research Personnel | 1 | 2019 | 151 | 0.140 |
Why?
| | Survival Rate | 2 | 2018 | 1642 | 0.140 |
Why?
| | Periodicals as Topic | 1 | 2019 | 181 | 0.140 |
Why?
| | Diphenoxylate | 1 | 2016 | 5 | 0.140 |
Why?
| | Atropine | 1 | 2016 | 25 | 0.140 |
Why?
| | Loperamide | 1 | 2016 | 10 | 0.140 |
Why?
| | Antidiarrheals | 1 | 2016 | 15 | 0.140 |
Why?
| | Nursing Assessment | 1 | 2017 | 49 | 0.140 |
Why?
| | Atrial Fibrillation | 1 | 2021 | 324 | 0.140 |
Why?
| | Patient Reported Outcome Measures | 3 | 2023 | 250 | 0.140 |
Why?
| | Cause of Death | 1 | 2018 | 362 | 0.140 |
Why?
| | Continuity of Patient Care | 1 | 2019 | 254 | 0.140 |
Why?
| | Pressure Ulcer | 1 | 2017 | 31 | 0.140 |
Why?
| | Referral and Consultation | 1 | 2021 | 632 | 0.140 |
Why?
| | Terminally Ill | 1 | 2016 | 33 | 0.140 |
Why?
| | Voltage-Gated Sodium Channel Blockers | 1 | 2016 | 5 | 0.140 |
Why?
| | Mineralocorticoid Receptor Antagonists | 1 | 2016 | 38 | 0.130 |
Why?
| | Prosthesis Design | 2 | 2016 | 285 | 0.130 |
Why?
| | Patient Care Management | 1 | 2016 | 53 | 0.130 |
Why?
| | Chromatography, Gas | 1 | 2016 | 27 | 0.130 |
Why?
| | Mortality | 1 | 2018 | 288 | 0.130 |
Why?
| | Consumer Health Information | 1 | 2016 | 47 | 0.130 |
Why?
| | Advanced Practice Nursing | 1 | 2016 | 22 | 0.130 |
Why?
| | Gastrointestinal Agents | 1 | 2016 | 60 | 0.130 |
Why?
| | Health Policy | 2 | 2020 | 334 | 0.130 |
Why?
| | Arrhythmias, Cardiac | 1 | 2018 | 278 | 0.130 |
Why?
| | Truth Disclosure | 1 | 2016 | 39 | 0.130 |
Why?
| | Canada | 1 | 2017 | 322 | 0.130 |
Why?
| | Defibrillators, Implantable | 2 | 2016 | 286 | 0.130 |
Why?
| | Reproducibility of Results | 3 | 2023 | 2763 | 0.130 |
Why?
| | Drug Combinations | 1 | 2016 | 286 | 0.130 |
Why?
| | Uncertainty | 1 | 2016 | 96 | 0.130 |
Why?
| | Hospices | 1 | 2016 | 83 | 0.130 |
Why?
| | Patient Care Planning | 1 | 2016 | 139 | 0.130 |
Why?
| | Social Security | 1 | 2015 | 4 | 0.130 |
Why?
| | Sex Distribution | 1 | 2016 | 335 | 0.130 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 179 | 0.130 |
Why?
| | Medical Indigency | 1 | 2015 | 11 | 0.130 |
Why?
| | Aged, 80 and over | 3 | 2016 | 6350 | 0.130 |
Why?
| | Diagnosis-Related Groups | 1 | 2015 | 27 | 0.130 |
Why?
| | Workload | 1 | 2016 | 132 | 0.130 |
Why?
| | Patient Selection | 1 | 2019 | 641 | 0.130 |
Why?
| | Nurse's Role | 1 | 2016 | 106 | 0.120 |
Why?
| | Social Support | 2 | 2020 | 528 | 0.120 |
Why?
| | Health Care Costs | 1 | 2018 | 380 | 0.120 |
Why?
| | Multimedia | 1 | 2014 | 10 | 0.120 |
Why?
| | Factor X | 1 | 2014 | 24 | 0.120 |
Why?
| | Fee-for-Service Plans | 1 | 2015 | 83 | 0.120 |
Why?
| | Needs Assessment | 1 | 2016 | 313 | 0.120 |
Why?
| | Central Nervous System Stimulants | 1 | 2016 | 139 | 0.120 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2016 | 287 | 0.120 |
Why?
| | Assisted Circulation | 1 | 2014 | 25 | 0.120 |
Why?
| | Mass Screening | 1 | 2021 | 1003 | 0.120 |
Why?
| | Family Relations | 1 | 2015 | 85 | 0.120 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2015 | 99 | 0.120 |
Why?
| | Treatment Refusal | 1 | 2015 | 85 | 0.120 |
Why?
| | Sex Factors | 2 | 2016 | 1717 | 0.120 |
Why?
| | Length of Stay | 2 | 2017 | 949 | 0.120 |
Why?
| | Patient Discharge | 2 | 2022 | 769 | 0.110 |
Why?
| | Population Surveillance | 1 | 2017 | 392 | 0.110 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 994 | 0.110 |
Why?
| | Cooperative Behavior | 1 | 2016 | 381 | 0.110 |
Why?
| | Follow-Up Studies | 5 | 2023 | 4420 | 0.110 |
Why?
| | Risk | 1 | 2016 | 815 | 0.110 |
Why?
| | Cohort Studies | 1 | 2023 | 4901 | 0.110 |
Why?
| | Pain Management | 1 | 2016 | 289 | 0.110 |
Why?
| | Heparin | 1 | 2014 | 222 | 0.110 |
Why?
| | Imaging, Three-Dimensional | 1 | 2016 | 513 | 0.100 |
Why?
| | Immunosuppressive Agents | 1 | 2016 | 647 | 0.100 |
Why?
| | Severity of Illness Index | 2 | 2017 | 2539 | 0.100 |
Why?
| | Antibodies | 1 | 2014 | 371 | 0.100 |
Why?
| | Program Evaluation | 1 | 2016 | 822 | 0.100 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1178 | 0.100 |
Why?
| | Pilot Projects | 1 | 2016 | 1370 | 0.100 |
Why?
| | Acute Disease | 1 | 2014 | 912 | 0.100 |
Why?
| | Motivation | 1 | 2015 | 494 | 0.090 |
Why?
| | Health Behavior | 1 | 2016 | 704 | 0.090 |
Why?
| | Prevalence | 1 | 2016 | 2249 | 0.090 |
Why?
| | Internet | 1 | 2014 | 596 | 0.090 |
Why?
| | Comorbidity | 3 | 2020 | 1449 | 0.090 |
Why?
| | Attitude of Health Personnel | 1 | 2016 | 977 | 0.080 |
Why?
| | Prognosis | 4 | 2018 | 3334 | 0.080 |
Why?
| | Disease Progression | 1 | 2016 | 2387 | 0.080 |
Why?
| | Incidence | 1 | 2014 | 2312 | 0.080 |
Why?
| | Bayes Theorem | 2 | 2019 | 331 | 0.070 |
Why?
| | Academic Medical Centers | 2 | 2020 | 413 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 1 | 2016 | 2269 | 0.070 |
Why?
| | Disease Management | 2 | 2022 | 560 | 0.070 |
Why?
| | Time Factors | 3 | 2023 | 6124 | 0.070 |
Why?
| | Young Adult | 2 | 2016 | 10463 | 0.060 |
Why?
| | Information Systems | 1 | 2023 | 61 | 0.050 |
Why?
| | Patient Care | 1 | 2023 | 103 | 0.050 |
Why?
| | Death | 1 | 2022 | 107 | 0.050 |
Why?
| | Age Factors | 2 | 2019 | 2890 | 0.040 |
Why?
| | Aftercare | 1 | 2022 | 186 | 0.040 |
Why?
| | Health Services Misuse | 1 | 2020 | 36 | 0.040 |
Why?
| | Role | 1 | 2020 | 32 | 0.040 |
Why?
| | Hospitals, Community | 1 | 2020 | 45 | 0.040 |
Why?
| | Thromboembolism | 1 | 2021 | 93 | 0.040 |
Why?
| | Pharmacogenomic Testing | 1 | 2020 | 53 | 0.040 |
Why?
| | Social Responsibility | 1 | 2020 | 45 | 0.040 |
Why?
| | Income | 1 | 2020 | 167 | 0.040 |
Why?
| | Tertiary Care Centers | 1 | 2020 | 126 | 0.040 |
Why?
| | Contracts | 1 | 2019 | 9 | 0.040 |
Why?
| | Contraindications, Procedure | 1 | 2019 | 11 | 0.040 |
Why?
| | Pharmacogenetics | 1 | 2020 | 149 | 0.040 |
Why?
| | Visual Analog Scale | 1 | 2019 | 31 | 0.040 |
Why?
| | Self Efficacy | 1 | 2022 | 355 | 0.040 |
Why?
| | Colorado | 2 | 2020 | 4086 | 0.040 |
Why?
| | Area Under Curve | 1 | 2019 | 275 | 0.040 |
Why?
| | International Cooperation | 1 | 2019 | 172 | 0.040 |
Why?
| | Social Determinants of Health | 1 | 2020 | 135 | 0.040 |
Why?
| | Administration, Oral | 1 | 2021 | 731 | 0.040 |
Why?
| | Survival | 1 | 2018 | 37 | 0.040 |
Why?
| | Adolescent | 1 | 2016 | 17808 | 0.040 |
Why?
| | Health Services Needs and Demand | 1 | 2020 | 244 | 0.040 |
Why?
| | Walk Test | 1 | 2018 | 52 | 0.040 |
Why?
| | Health Status | 1 | 2023 | 723 | 0.040 |
Why?
| | Postoperative Complications | 2 | 2019 | 2127 | 0.040 |
Why?
| | Viral Load | 1 | 2019 | 405 | 0.040 |
Why?
| | ROC Curve | 1 | 2019 | 445 | 0.040 |
Why?
| | Random Allocation | 1 | 2018 | 335 | 0.040 |
Why?
| | Intraoperative Care | 1 | 2017 | 34 | 0.040 |
Why?
| | Equipment Design | 1 | 2019 | 508 | 0.040 |
Why?
| | Infusions, Intravenous | 1 | 2018 | 372 | 0.040 |
Why?
| | Health Surveys | 1 | 2019 | 443 | 0.040 |
Why?
| | Nurses | 1 | 2019 | 145 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2019 | 4409 | 0.030 |
Why?
| | Hemorrhage | 1 | 2021 | 618 | 0.030 |
Why?
| | Frail Elderly | 1 | 2017 | 105 | 0.030 |
Why?
| | Postoperative Care | 1 | 2017 | 219 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1340 | 0.030 |
Why?
| | Video Recording | 1 | 2016 | 142 | 0.030 |
Why?
| | Societies, Medical | 1 | 2019 | 663 | 0.030 |
Why?
| | Life Change Events | 1 | 2016 | 135 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 935 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2018 | 479 | 0.030 |
Why?
| | Reference Values | 1 | 2016 | 742 | 0.030 |
Why?
| | Databases, Factual | 1 | 2019 | 1128 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2019 | 646 | 0.030 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2019 | 486 | 0.030 |
Why?
| | Survival Analysis | 1 | 2016 | 1218 | 0.030 |
Why?
| | Stroke | 1 | 2021 | 1019 | 0.030 |
Why?
| | Algorithms | 1 | 2019 | 1468 | 0.030 |
Why?
| | Telemedicine | 1 | 2020 | 663 | 0.020 |
Why?
| | Quality of Health Care | 1 | 2016 | 573 | 0.020 |
Why?
| | Body Mass Index | 1 | 2019 | 1958 | 0.020 |
Why?
| | Anxiety | 1 | 2016 | 842 | 0.020 |
Why?
| | Cognition | 1 | 2016 | 989 | 0.020 |
Why?
| | Hypertension, Pulmonary | 1 | 2019 | 1728 | 0.020 |
Why?
| | Child | 1 | 2022 | 18352 | 0.010 |
Why?
|
|
McIlvennan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|